EUVIMEDEUVIMED entdecken
Crossref

Design and synthesis of luotonin A-derived topoisomerase targeting scaffold with potent antitumor effect and low genotoxicity

Xin-Wei Li, Shu-Jun Fang, Ying-Ze Li, Li-Qing Qin, Nan-Ying Chen, Bin Zheng, Dong-Liang Mo, Gui-Fa Su, Jun-Cheng Su, Cheng-Xue Pan

Bioorganic Chemistry · 2024

DOI: 10.1016/j.bioorg.2023.107015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2024. Verfasst von Xin-Wei Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medici…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 58 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Conventional topoisomerase (Topo) inhibitors typically usually exert their cytotoxicity by damaging the DNAs, which exhibit high toxicity and tend to result in secondary carcinogenesis risk. Molecules that have potent topoisomerase inhibitory activity but involve less DNA damage provide more desirable scaffolds for developing novel chemotherapeutic agents. In this work, we broke the rigid pentacyclic system of luotonin A and synthesized thirty-three compounds as potential Topo inhibitors based on the devised molecular motif. Further investigation disclose that two compounds with the highest antiproliferation activity against cancer cells, 5aA and 5dD, had a distinct Topo I inhibitory mechanism different from those of the classic Topo I inhibitors CPT or luteolin, and were able to obviate the obvious cellular DNA damage typically associated with clinically available Topo inhibitors. The animal model experiments demonstrated that even in mice treated with a high dosage of 50 mg/kg 5aA, there were no obvious signs of toxicity or loss of body weight. The tumor growth inhibition (TGI) rate was 54.3 % when 20 mg/kg 5aA was given to the T24 xenograft mouse model, and 5aA targeted the cancer tissue precisely without causing damage to the liver and other major organs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsNeoplasmsHumansAnimalsMiceQuinonesPyrrolesTopoisomerase I InhibitorsDNA DamageDNA Topoisomerases, Type ITopoisomerase II InhibitorsDNA Topoisomerases, Type IICell Line, Tumor

Stichwörter der Autor:innen

AnticancerGenotoxicityLuotonin ATopoisomerase inhibition

Substanzen

luotonin AAntineoplastic AgentsQuinonesPyrrolesTopoisomerase I InhibitorsDNA Topoisomerases, Type ITopoisomerase II InhibitorsDNA Topoisomerases, Type II

Autor:innen und Institutionen

  • State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Collaborative Innovati…

Zitieren

APA

Li, X. W., Fang, S. J., Li, Y. Z., Qin, L. Q., Chen, N. Y., Zheng, B., Mo, D. L., Su, G. F., Su, J. C., & Pan, C. X. (2024). Design and synthesis of luotonin A-derived topoisomerase targeting scaffold with potent antitumor effect and low genotoxicity. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2023.107015

Vancouver

Li XW, Fang SJ, Li YZ, Qin LQ, Chen NY, Zheng B, et al. Design and synthesis of luotonin A-derived topoisomerase targeting scaffold with potent antitumor effect and low genotoxicity. Bioorganic Chemistry. 2024. doi:10.1016/j.bioorg.2023.107015

BibTeX
@article{Li2024,
  author = {Li, Xin-Wei and Fang, Shu-Jun and Li, Ying-Ze and Qin, Li-Qing and Chen, Nan-Ying and Zheng, Bin and Mo, Dong-Liang and Su, Gui-Fa and Su, Jun-Cheng and Pan, Cheng-Xue},
  title = {Design and synthesis of luotonin A-derived topoisomerase targeting scaffold with potent antitumor effect and low genotoxicity},
  journal = {Bioorganic Chemistry},
  year = {2024},
  doi = {10.1016/j.bioorg.2023.107015}
}
Kostenlos starten →